Skip to main content
Division of Infectious Diseases & Global Public Health IDGPH

Industry Partners

Adaptive Phage Therapeutics, Inc. (APT)

apt-logo.jpg

Adaptive Phage Therapeutics, Inc. (APT) is a clinical-stage company founded to provide an effective therapeutic response to the global rise of multi-drug resistant (MDR) pathogenic bacteria.